Health Management Associates
New Federal PBM Transparency Rules Signal Broader Oversight Trend
The piece reviews early 2026 federal actions tightening oversight of pharmacy benefit managers, including new DOL disclosure rules, the Consolidated Appropriations Act of 2026's transparency and compensation restrictions for Medicare Part D, and an FTC settlement with Express Scripts. While the analysis centers on commercial insurance and Medicare Part D, the compensation and contracting reforms described are relevant to Medicaid managed care plans that rely on PBM arrangements and may face similar transparency pressures as CMS implementation unfolds.
This is outside commentary from Health Management Associates, not part of Medicaid Monitor's independently scored news coverage.